Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment (original) (raw)

• Bassetti, C. & Aldrich, M. Narcolepsy. Neurol. Clin. 14, 545–571 (1996).
  Article CAS PubMed Google Scholar
• Westphal, C. Eigentümliche mit Einschlafen verbundene Anfälle. Arch. Psychiatr. Nervenkr. 7, 631–635 (1877).
  Google Scholar
• Gélineau, J. B. E. De la narcolepsie [French]. Gaz. Hop. 53–54, 626–637 (1880).
  Google Scholar
• Fischer, F. Epileptoide Schlafzustände [German]. Arch. Psychiatr. Nervenkr. 8, 200–203 (1878).
  Article Google Scholar
• Henneberg, R. Über genuine Narkolepsie [German]. Neurol. Zbl. 30, 282–290 (1916).
  Google Scholar
• Löwenfeld, L. Über Narkolepsie [German]. Münch. Med. Wochenschr. 49, 1041–1045 (1902).
  Google Scholar
• Redlich, E. Zur Narkolepsiefrage [German]. Monatsschr. Psychiatr. Neurol. 37, 85 (1915).
  Article Google Scholar
• Redlich, E. Über Narkolepsie [German]. Z. Gesamte Neurol. Psychiatr. 95, 256–270 (1924).
  Article Google Scholar
• Daniels, L. E. Narcolepsy. Medicine 13, 1–122 (1934).
  Article Google Scholar
• Yoss, R. E. & Daly, D. D. Criteria for the diagnosis of the narcoleptic syndrome. Mayo Clin. Proc. 32, 320–328 (1957).
  CAS Google Scholar
• Wilder, J. in Handbuch der Neurologie Vol. 17 (eds Braun, E., Bumke, O. & Förster, O.) 87–141 (Springer, 1935).
• Adie, W. J. Idiopathic narcolepsy: a disease sui generis; with remarks on the mechanism of sleep. Brain 49, 257–306 (1926).
  Article Google Scholar
• Wilson, S. A. The narcolepsies. Brain 51, 63–109 (1928).
  Article Google Scholar
• Vogel, G. Studies in psychophysiology of dreams III. The dreams of narcolepsy. Arch. Gen. Psychiatry 3, 421–428 (1960).
  Article CAS PubMed Google Scholar
• Honda, Y., Asaka, A., Tanaka, Y. & Juji, T. Discrimination of narcolepsy by using genetic markers and HLA. Sleep Res. 12, 254 (1983).
  Google Scholar
• Juji, T., Satake, M., Honda, Y. & Doi, Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 24, 316–319 (1984).
  Article CAS PubMed Google Scholar
• Nishino, N., Ripley, B., Overeem, S., Lammers, G. J. & Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39–40 (2000).
  Article CAS PubMed Google Scholar
• American Academy of Sleep Medicine. International Classification of Sleep Disorders (ICSD-3) 3rd edn (AASM, 2014).
• Juji, T., Matsuki, L., Tokunaga, K., Naohara, K. & Honda, Y. Narcolepsy and HLA in the Japanese. Ann. NY Acad. Sci. 540, 106–114 (1988).
  Article CAS PubMed Google Scholar
• Hublin, S. et al. The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort. Ann. Neurol. 35, 709–716 (1994).
  Article CAS PubMed Google Scholar
• Silber, M. H., Krahn, L. E., Olson, E. J. & Pankratz, V. S. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep 25, (197–202 (2002).
  Google Scholar
• Ohayon, M., Priest, R. G., Zulley, J., Smirne, S. & Paiva, T. Prevalence of narcolepsy symptomatology and diagnosis in the European general population. Neurology 58, 1826–1833 (2002).
  Article CAS PubMed Google Scholar
• Wilner, A. et al. Narcolepsy-cataplexy in Israeli Jews is associated exclusively with the HLA DR2 haplotype. Hum. Immunol. 21, 15–22 (1988).
  Article CAS PubMed Google Scholar
• al Rajeh, S. et al. A community survey of neurological disorders in Saudi Arabia: the Thugbah study. Neuroepidemiology 12, 164–178 (1993).
  Article CAS PubMed Google Scholar
• Jennum, J., Ibsen, R., Petersen, E. R., Knudsen, S. & Kjellberg, J. Health, social and economic consequences of narcolepsy: a controlled national study evaluating the societal effect on patients and their partners. Sleep Med. 13, 1086–1093 (2012).
  Article PubMed Google Scholar
• Jennum, P., Thorstensen, E. W., Pickering, L., Ibsen, R. & Kjellberg, J. Morbidity and mortality of middle-aged and elderly narcoleptics. Sleep Med. 36, 23–28 (2017).
  Article PubMed Google Scholar
• Dauvilliers, Y. et al. Age at onset of narcolepsy in two large populations of patients in France and Quebec. Neurology 57, 2029–2033 (2001).
  Article CAS PubMed Google Scholar
• Rocca, F. L., Pizza, F., Ricci, E. & Plazzi, G. Narcolepsy during childhood: an update. Neuropediatrics 46, 181–198 (2015).
  Article PubMed Google Scholar
• Yoss, R. & Daly, D. Narcolepsy in children. Pediatrics 25, 1025–1033 (1960).
  CAS PubMed Google Scholar
• Challamel, M. J. et al. Narcolepsy in children. Sleep 17, 17–20 (1994).
  Article Google Scholar
• Guilleminault, C. & Pelayo, R. Narcolepsy in prepubertal children. Ann. Neurol. 43, 135–142 (1998).
  Article CAS PubMed Google Scholar
• Pizza, F. et al. Primary progressive narcolepsy type 1: the other side of the coin. Neurology 83, 2189–2190 (2014).
  Article PubMed PubMed Central Google Scholar
• Luca, G. et al. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J. Sleep Res. 22, 482–495 (2013).
  Article PubMed Google Scholar
• Sturzenegger, C. & Bassetti, C. L. The clinical spectrum of narcolepsy with cataplexy: a reappraisal. J. Sleep Res. 13, 395–406 (2004).
  Article PubMed Google Scholar
• van Dijk, J. G., Lammers, G. J. & Blansjaar, B. A. Isolated cataplexy of more than 40 years’ duration. Br. J. Psychiatry 159, 719–721 (1991).
  Article PubMed Google Scholar
• Andlauer, O. et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 35, 1247–1255 (2012).
  Article PubMed PubMed Central Google Scholar
• Trotti, L. M., Staab, B. A. & Rye, D. B. Test-retest reliability of the multiple sleep latency test in narcolepsy without cataplexy and idiopathic hypersomnia. J. Clin. Sleep Med. 9, 789–785 (2013).
  PubMed PubMed Central Google Scholar
• Lopez, R. et al. Test-retest reliability of the multiple sleep latency test in central disorders of hypersomnolence. Sleep 40, 164–168 (2017).
  Google Scholar
• Dauvilliers, Y., Abril, B., Mas, E., Michel, F. & Tafti, M. Normalization of hypocretin-1 in narcolepsy after intravenous immunoglobulin treatment. Neurology 73, 1333–1334 (2009).
  Article CAS PubMed Google Scholar
• Symonds, C. P. Narcolepsy as a symptom of encephalitis lethargica. Lancet 173, 1214–1125 (1922).
  Google Scholar
• Mankowski, B. Zur Pathogenese kataplegisches Anfälle bei Narkolepsie (auf Grund eines Falls von Encephalitis epidemica) [German]. Monatschr. Psychiatr. Neurol. 61, 340–349 (1926).
  Article Google Scholar
• Langdon, N., Welsh, K. I., van Dam, M., Vaughan, R. W. & Parkes, D. Genetic markers in narcolepsy. Lancet 2, 1178–1180 (1984).
  Article CAS PubMed Google Scholar
• Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991–997 (2000).
  Article CAS PubMed Google Scholar
• Thannickal, T. C. et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469–474 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Crocker, A. et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology 65, 1184–1188 (2005).
  Article CAS PubMed Google Scholar
• de Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA 95, 322–327 (1998).
  Article PubMed PubMed Central Google Scholar
• Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573–585 (1998).
  Article CAS PubMed Google Scholar
• Krahn, L. E. Reevaluating spells initially identified as cataplexy. Sleep Med. 6, 537–542 (2005).
  Article PubMed Google Scholar
• Desseilles, M. et al. Neuroimaging insights into the pathophysiology of sleep disorders. Sleep 31, 777–794 (2008).
  Article PubMed PubMed Central Google Scholar
• Burgess, C. R. & Scammell, T. E. Narcolepsy: neural mechanisms of sleepiness and cataplexy. J. Neurosci. 32, 12305–12311 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Broughton, R. et al. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. Sleep 9, 205–215 (1986).
  Article CAS PubMed Google Scholar
• Nishino, S. & Kanbayashi, T. Symptomatic narcolepsy, cataplexy, and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Sleep Med. Rev. 9, 269–310 (2005).
  Article PubMed Google Scholar
• Baumann, C. R. et al. Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury. Neurology 65, 147–149 (2005).
  Article CAS PubMed Google Scholar
• Baumann, C. R. et al. Loss of hypocretin (orexin) neurons with trumatic brain injury. Ann. Neurol. 66, 555–559 (2009).
  Article PubMed PubMed Central Google Scholar
• Baumann, C. R., Bassetti, C. L., Hersberger, M. & Jung, H. H. Excessive daytime sleepiness in Behçet’s disease with diencephalic lesions and hypocretin dysfunction. Eur. Neurol. 63, 190 (2010).
  Article PubMed Google Scholar
• Mignot, E. et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch. Neurol. 59, 1553–1562 (2002).
  Article PubMed Google Scholar
• Bassetti, C. L. Selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies. Neurology 65, 1152–1153 (2005).
  Article PubMed Google Scholar
• Latorre, D. et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons. Nature 562, 63–68 (2018).
  Article CAS PubMed Google Scholar
• Lippert, J. et al. Specific T cell activation in peripheral blood and cerebrospinal fluid in central disorders of hypersomnolence. Sleep 42, zsy223 (2019).
  Article Google Scholar
• Luo, F. et al. Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy. Proc. Natl Acad. Sci. USA 115, E12323–E12332 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Pedersen, N. W. et al. CD8+ T cells from patients with narcolepsy and healthy controls recognize hypocretin neuron-specific antigens. Nat. Commun. 10, 837 (2019).
  Article PubMed PubMed Central CAS Google Scholar
• Thannickal, T. C., Nienhuis, R. & Siegel, J. M. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 32, 993–998 (2009).
  Article PubMed PubMed Central Google Scholar
• Valko, P. O. et al. Increase of histaminergic tuberomammillary neurons in narcolepsy. Ann. Neurol. 74, 794–804 (2013).
  Article CAS PubMed Google Scholar
• Honda, M. et al. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy. Neurology 18, 511–517 (2009).
  Article CAS Google Scholar
• Gerashchenko, D. et al. Relationship between CSF hypocretin levels and hypocretin neuronal loss. Exp. Neurol. 184, 1010–1016 (2003).
  Article CAS PubMed Google Scholar
• John, J. et al. Greatly increased numbers of histamine cells in human narcolepsy with cataplexy. Ann. Neurol. 74, 786–793 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Khatami, R. et al. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway. Lancet 363, 1199–1200 (2004).
  Article CAS PubMed Google Scholar
• Dauvilliers, Y. et al. A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1. Neurology 62, 2137–2138 (2004).
  Article CAS PubMed Google Scholar
• Hor, H. et al. A missense mutation in myelin oligdendrocyte glycoprotein as a cause of familial narcolepsy with cataplexy. Am. J. Hum. Genet. 89, 474–479 (2011).
  Article CAS PubMed PubMed Central Google Scholar
• Degn, M. et al. Rare missense mutations in P2RY11 in narcolepsy with cataplexy. Brain 140, 1657–1668 (2017).
  Article PubMed Google Scholar
• Mignot, E. Genetic and familial aspects of narcolepsy. Neurology 50, S16–S22 (1998).
  Article CAS PubMed Google Scholar
• Dauvilliers, Y. et al. A narcolepsy susceptibility locus maps to a 5 Mb region of chromosome 21q. Ann. Neurol. 56, 382–388 (2004).
  Article CAS PubMed Google Scholar
• Mignot, E. et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am. J. Hum. Genet. 68, 686–699 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Tafti, M. et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 37, 19–25 (2014).
  Article PubMed PubMed Central Google Scholar
• Mignot, E., Young, T., Lin, L., Finn, L. & Palta, M. Reduction of REM sleep latency associated with HLA-DQB1*0602 in normal adults. Lancet 351, 727 (1998).
  Article CAS PubMed Google Scholar
• Ollila, H. M. et al. HLA-DPB1 and HLA class I confer risk of and protection from narcolepsy. Am. J. Hum. Genet. 96, 136–146 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Han, F. et al. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLOS Genet. 9, e1003880 (2013).
  Article PubMed PubMed Central CAS Google Scholar
• Tafti, M. et al. Narcolepsy-associated HLA class I alleles implicate cell-mediated cytotoxicity. Sleep 39, 581–587 (2016).
  Article PubMed PubMed Central Google Scholar
• Hor, H. et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat. Genet. 42, 786–789 (2010).
  Article CAS PubMed Google Scholar
• Hallmayer, J. et al. Narcolepsy is strongly associated with the T cell receptor alpha locus. Nat. Genet. 41, 708–711 (2009).
  Article CAS PubMed PubMed Central Google Scholar
• Faraco, J. et al. Immunochip study implicates antigen presentation to T cells in narcolepsy. PLOS Genet. 9, e1003270 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Kornum, B. R. et al. Common variants in P2RY11 are associated with narcolepsy. Nat. Genet. 43, 66–71 (2011).
  Article CAS PubMed Google Scholar
• Singh, A. K., Mahlios, J. & Mignot, E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J. Autoimmun. 43, 26–31 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Shimada, M., Miyagawa, T., Toyoda, H., Tokunaga, K. & Honda, M. Epigenome-wide association study of DNA methylation in narcolepsy: an integrated genetic and epigenetic approach. Sleep 41, zsy019 (2018).
  Article Google Scholar
• Imlah, N. W. Narcolepsy in identical twins. J. Neurol. Neurosurg. Psychiatry 24, 158–160 (1961).
  Article CAS PubMed PubMed Central Google Scholar
• Pollmächer, T. et al. DR2-positive monozygotic twins discordant for narcolepsy. Sleep 13, 336–343 (1990).
  Article PubMed Google Scholar
• Partinen, M., Hublin, C., Kaprio, J., Koskenvuo, M. & Guilleminault, C. Twin studies in narcolepsy. Sleep 17, S13–S16 (1994).
  Article CAS PubMed Google Scholar
• Dahmen, N. & Tonn, P. Season of birth effect in narcolepsy. Neurology 61, 1016–1017 (2003).
  Article PubMed Google Scholar
• Dauvilliers, Y. et al. Month of birth as a risk factor for narcolepsy. Sleep 26, 663–665 (2003).
  Article PubMed Google Scholar
• Picchioni, D., Mignot, E. & Harsh, J. R. The month-of-birth pattern in narcolepsy is moderated by cataplexy severity and may be independent of HLA-DQB1*0602. Sleep 27, 1471–1475 (2004).
  Article PubMed Google Scholar
• Donjacour, C. E., Fronczek, R., Le Cessie, Lammers, S., G. J. & Van Dijk, J. G. Month of birth is not a risk factor for narcolepsy with cataplexy in the Netherlands. J. Sleep Res. 20, 522–525 (2011).
  Article PubMed Google Scholar
• von Economo, C. Sleep as a problem of localization. J. Nerv. Ment. Dis. 71, 249–259 (1930).
  Article Google Scholar
• Aran, A. et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 32, 979–993 (2009).
  Article PubMed PubMed Central Google Scholar
• Partinen, M. et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol. 13, 600–613 (2014).
  Article CAS PubMed Google Scholar
• Dauvilliers, Y. et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 136, 2486–2496 (2013).
  Article PubMed Google Scholar
• Ahmed, S. S. et al. Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2. Sci. Transl Med. 7, 294ra105 (2015).
  Article PubMed CAS Google Scholar
• Saariaho, A. H. et al. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. J. Autoimmun. 63, 68–75 (2015).
  Article CAS PubMed Google Scholar
• Han, F., Lin, L., Li, J., Dong, X. S. & Mignot, E. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann. Neurol. 73, 560 (2013).
  Article PubMed Google Scholar
• Sarkanen, T., Alakuijala, A., Julkunen, I. & Partinen, M. Narcolepsy associated with Pandemrix vaccine. Curr. Neurol. Neurosci. Rep. 18, 43 (2018).
  Article PubMed CAS Google Scholar
• Heyck, H. & Hess, R. Some results of clinical studies on narcolepsy. Schweiz. Arch. Neurol. Psychiatr. 75, 401–402 (1955).
  CAS PubMed Google Scholar
• Hidalgo, H., Kallweit, U., Mathis, J. & Bassetti, C. L. Post Tick-borne encephalitis virus vaccination narcolepsy with cataplexy. Sleep 39, 1811–1814 (2016).
  Article PubMed PubMed Central Google Scholar
• Lankford, D. A., Wellmann, J. J. & O’Hara, C. Posttraumatic narcolepsy in mild to moderate closed head injury. Sleep 17, S25–S28 (1994).
  Article CAS PubMed Google Scholar
• Silber, M. H. Narcolepsy, head injury, and the problem of causality. J. Clin. Sleep Med. 1, 157–158 (2005).
  PubMed Google Scholar
• Cvetikovic-Lopes, V. et al. Elevated Tribbles homolog-2-specific antibody levels in narcolepsy patients. J. Clin. Invest. 120, 713–719 (2010).
  Article CAS Google Scholar
• Bergman, H. et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc. Natl Acad. Sci. USA 111, E3735–E3744 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Kallweit, U. et al. Co-existing narcolepsy (with and without cataplexy) and multiple sclerosis: six new cases and a literature review. J. Neurol. 265, 2071–2078 (2018).
  Article CAS PubMed Google Scholar
• Ekbom, K. Familial multiple sclerosis associated with narcolepsy. Arch. Neurol. 15, 337–344 (1966).
  Article CAS PubMed Google Scholar
• Tsutsui, K. et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 12, 37 (2012).
  Article PubMed PubMed Central Google Scholar
• Overeem, S. et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology 62, 138–140 (2004).
  Article CAS PubMed Google Scholar
• Dauvilliers, Y. et al. Hypothalamic immunopathology in anti-Ma–associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 70, 1305–1310 (2013).
  PubMed Google Scholar
• Peraita-Adrados, R. et al. A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms? Sleep Med. 14, 695–696 (2013).
  Article PubMed Google Scholar
• Valko, P. O., Khatami, R., Baumann, C. R. & Bassetti, C. L. No effect of intravenous immunoglobulins in patents with narcolepsy with cataplexy. J. Neurol. 255, 1900–1903 (2008).
  Article PubMed Google Scholar
• Chen, W., Black, J., Call, P. & Mignot, E. Late-onset narcolepsy presenting as rapidly progressing muscle weakness: response to plasmapheresis. Ann. Neurol. 58, 489–490 (2005).
  Article PubMed Google Scholar
• Lecendreux, M., Maret, S., Bassetti, C., Mouren, M. C. & Tafti, M. Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy. J. Sleep Res. 12, 347–348 (2003).
  Article PubMed Google Scholar
• Black, J. L. 3rd et al. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Sleep 28, 427–431 (2005).
  Article PubMed Google Scholar
• Tanaka, S., Honda, Y., Inoue, Y. & Honda, M. Detection of autoantibodies against hypocretin, HCRTR1, and HCRTR2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep 29, 633–638 (2006).
  Article PubMed Google Scholar
• Giannoccaro, M. P. et al. Antibodies against hypocretin receptor 2 are rare in narcolepsy. Sleep 40, zsw056 (2017).
  Article Google Scholar
• Langdon, N. et al. Immune factors in narcolepsy. Sleep 9, 143–148 (1986).
  Article CAS PubMed Google Scholar
• Fredrikson, S., Carlander, B., Billiard, M. & Link, H. CSF immune variables in patients with narcolepsy. Acta Neurol. Scand. 81, 253–254 (1990).
  Article CAS PubMed Google Scholar
• Hartmann, F. J. et al. High-dimensional single-cell analysis reveals the immune signature of narcolepsy. J. Exp. Med. 213, 2621–2633 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Ramberger, M. et al. CD4+ T cell reactivity to orexin/hypocretin in patients with narcolepsy type 1. Sleep 40, zsw070 (2017).
  Article Google Scholar
• Lecendreux, M. et al. Impact of cytokine in type 1 narcolepsy: role of pandemic H1N1 vaccination? J. Autoimmun. 60, 20–31 (2015).
  Article CAS PubMed Google Scholar
• Lecendreux, M. et al. Narcolepsy type 1 is associated with a systemic increase and activation of regulatory T cells and with a systemic activation of global T cells. PLOS ONE 12, e0169836 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Khatami, R. et al. The European Narcolepsy Network (EU-NN) database. J. Sleep Res. 25, 356–364 (2016).
  Article PubMed Google Scholar
• Kornum, B. R. et al. Narcolepsy. Nat. Rev. Dis. Primers 3, 16100 (2017).
  Article PubMed Google Scholar
• Guilleminault, C., Philips, R. & Dement, W. C. A syndrome of hypersomnia with automatic behaviour. Electroencephalogr. Clin. Neurophysiol. 38, 403–413 (1975).
  Article CAS PubMed Google Scholar
• Valko, P. O., Bassetti, C. L., Bloch, K. E., Held, U. & Baumann, C. R. Validation of the fatigue severity scale in a Swiss cohort. Sleep 31, 1601–1607 (2008).
  Article PubMed PubMed Central Google Scholar
• Droogleever Fortuyn, H. A. et al. Severe fatigue in narcolepsy with cataplexy. J. Sleep Res. 21, 163–169 (2012).
  Article PubMed Google Scholar
• Overeem, S. et al. The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency. Sleep Med. 12, 12–18 (2011).
  Article PubMed Google Scholar
• Pizza, F. et al. The distinguishing motor features of cataplexy: a study from video-recorded attacks. Sleep 41, zsy026 (2018).
  Article Google Scholar
• Serra, L., Montagna, P., Mignot, E., Lugaresi, E. & Plazzi, G. Cataplexy features in childhood narcolepsy. Mov. Disord. 23, 858–865 (2008).
  Article PubMed Google Scholar
• Barateau, L. et al. Persistence of deep-tendon reflexes during partial cataplexy. Sleep Med. 45, 80–82 (2018).
  Article PubMed Google Scholar
• Antelmi, E., Vandi, S., Pizza, Liguori, F., R. & Plazzi, G. Parkinsonian tremor persisting during cataplexy. Sleep Med. 17, 174–176 (2016).
  Article CAS PubMed Google Scholar
• Poryazova, R., Siccoli, M., Werth, E. & Bassetti, C. L. Unusually prolonged rebound cataplexy after withdrawal of fluoxetine. Neurology 65, 967–968 (2005).
  Article PubMed Google Scholar
• Gelb, M. et al. Stability of cataplexy over several months — information for the design of therapeutic trials. Sleep 17, 265–273 (1994).
  Article CAS PubMed Google Scholar
• Rubboli, G. et al. A video-polygraphic analysis of the cataplectic attack. Clin. Neurophysiol. 111, S120–S128 (2000).
  Article PubMed Google Scholar
• Plazzi, G. et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 134, 3477–3489 (2011).
  Article PubMed PubMed Central Google Scholar
• Redlich, E. Epilegomena zur Narkolepsie-Frage [German]. Z. Ges. Neurol. Psychiatr. 136, 129–173 (1931).
  Article Google Scholar
• Roth, B. Narcolepsy and Hypersomnia (Karger, 1980).
• Rüther, E., Meier-Ewert, K. & Gallitz, A. Zur Symptomatologie des narkoleptischen syndroms [German]. Nervenarzt 43, 640–643 (1972).
  PubMed Google Scholar
• Attarian, H. P., Schenck, C. H. & Mahowald, M. W. Presumed REM sleep behavior disorder arising from cataplexy and wakeful dreaming. Sleep Med. 1, 131–133 (2000).
  Article CAS PubMed Google Scholar
• Poryazova, R., Khatami, R., Werth, E. & Bassetti, C. L. Weak with sex: sexual intercourse as a trigger for cataplexy. J. Sex. Med. 6, 2271–2277 (2009).
  Article PubMed Google Scholar
• Parkes, J. D., Chen, S. Y., Clift, S. J., Dahlitz, M. J. & Dunn, G. The clinical diagnosis of the narcoleptic syndrome. J. Sleep Res. 7, 41–52 (1997).
  Article Google Scholar
• Vgontzas, A. N., Sollenberger, S. E., Kales, A., Bixler, E. O. & Vela-Bueno, A. Narcolepsy-cataplexy and loss of sphincter control. Postgrad. Med. J. 72, 493–494 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Fortuyn, H. A. et al. Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia. Gen. Hosp. Psychiatry 31, 146–154 (2009).
  Article PubMed Google Scholar
• Wamsley, E., Donjacour, C. E., Scammell, T. E., Lammers, G. J. & Stickgold, R. Delusional confusion of dreaming and reality in narcolepsy. Sleep 37, 419–422 (2014).
  Article PubMed PubMed Central Google Scholar
• Roth, T. et al. Disrupted nighttime sleep in narcolepsy. J. Clin. Sleep Med. 9, 955–965 (2013).
  PubMed PubMed Central Google Scholar
• Gudden, H. Die physiologische und pathologische Schlaftrunkenheit [German]. Arch. Psychiat. 40, 989–1015 (1905).
  Article Google Scholar
• Mullington, J. & Broughton, R. Daytime sleep inertia in narcolepsy-cataplexy. Sleep 17, 69–76 (1994).
  CAS PubMed Google Scholar
• Broughton, R., Dunham, W., Weisskopf, M. & Rivers, M. Night sleep does not predict day sleep in narcolepsy. Electroencephalogr. Clin. Neurophysiol. 91, 67–70 (1994).
  Article CAS PubMed Google Scholar
• Harsh, J., Peszka, J., Hartwig, G. & Mitler, M. Night-time sleep and daytime sleepiness in narcolepsy. J. Sleep Res. 9, 309–316 (2000).
  Article CAS PubMed Google Scholar
• Mayer, G. & Meier-Ewert, K. Motor dyscontrol in sleep of narcoleptic patients (a lifelong development?). J. Sleep Res. 2, 143–148 (1993).
  Article CAS PubMed Google Scholar
• Nevsimalova, S., Prihodova, I., Kemlink, D., Lin, L. & Mignot, E. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy. Sleep Med. 8, 784–786 (2007).
  Article PubMed Google Scholar
• Pizza, F., Tartarotti, S., Poryazova, R., Baumann, C. R. & Bassetti, C. L. Sleep-disordered breathing and periodic limb movements in narcolepsy with cataplexy: a systematic analysis of 35 consecutive patients. Eur. Neurol. 70, 22–26 (2013).
  Article PubMed Google Scholar
• Knudsen, S., Gammeltoft, S. & Jennum, P. J. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency. Brain 133, 568–579 (2010).
  Article PubMed Google Scholar
• Dauvilliers, Y. et al. Periodic leg movements during sleep and wakefulness in narcolepsy. J. Sleep Res. 16, 333–339 (2007).
  Article PubMed Google Scholar
• Plazzi, G. et al. Restless legs syndrome is frequent in narcolepsy with cataplexy patients. Sleep 33, 689–694 (2010).
  Article PubMed PubMed Central Google Scholar
• Franceschini, C. et al. Motor events during REM sleep in patients with narcolepsy-cataplexy: a video-polysomnographic pilot study. Sleep Med. 12, S59–S63 (2011).
  Article PubMed Google Scholar
• Nightingale, S. et al. The association between narcolepsy and REM behavior disorder (RBD). Sleep Med. 6, 253–258 (2005).
  Article CAS PubMed Google Scholar
• Chokroverty, S. Sleep apnea in narcolepsy. Sleep 9, 250–253 (1986).
  Article CAS PubMed Google Scholar
• Sansa, G., Iranzo, A. & Santamaria, J. Obstructive sleep apnea in narcolepsy. Sleep Med. 11, 93–95 (2010).
  Article PubMed Google Scholar
• Dodet, P., Chavez, M., Leu-Semenescu, S., Golmard, J. L. & Arnulf, I. Lucid dreaming in narcolepsy. Sleep 38, 487–497 (2015).
  Article PubMed PubMed Central Google Scholar
• Rak, M. et al. Increased lucid dreaming frequency in narcolepsy. Sleep 38, 787–792 (2015).
  Article PubMed PubMed Central Google Scholar
• Bladin, P. F. Narcolepsy-cataplexy and psychoanalytic theory of sleep and dreams. J. Hist. Neurosci. 9, 203–217 (2000).
  Article CAS PubMed Google Scholar
• Willey, M. M. Sleep as an escape mechanism. Psychoanal. Rev. 11, 181–183 (1924).
  Google Scholar
• Missriegler, A. On the psychogenesis of narcolepsy. J. Nerv. Ment. Dis. 93, 141–162 (1941).
  Article Google Scholar
• Pai, M. N. Hypersomnia syndromes. Br. Med. J. 1, 522–524 (1950).
  Article CAS PubMed PubMed Central Google Scholar
• Orellana, C. et al. Life events in the year preceding the onset of narcolepsy. Sleep 17, S50–S53 (1994).
  Article CAS PubMed Google Scholar
• Broughton, R. et al. Life effects of narcolepsy in 180 patients from North America, Asia and Europe compared to matched controls. Can. J. Neurol. Sci. 8, 299–304 (1981).
  Article CAS PubMed Google Scholar
• Roth, B. & Nevsimalova, S. Depression in narcolepsy and hypersomnia. Schweiz. Arch. Neurol. Neurochir. Psychiatr. 116, 291–300 (1975).
  CAS PubMed Google Scholar
• Vourdas, A. et al. Narcolepsy and psychopathology: is there an association? Sleep Med. 3, 353–360 (2002).
  Article CAS PubMed Google Scholar
• Ohayon, M. M. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med. 14, 488–492 (2013).
  Article PubMed Google Scholar
• Ruoff, C. M. et al. High rates of psychiatric comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study of 9,312 patients in the United States. J. Clin. Psychiatry 78, 171–176 (2017).
  Article PubMed Google Scholar
• Cohen, A., Mandrekar, J., St Louis, E. K., Silber, M. H. & Kotagal, S. Comorbidities in a community sample of narcolepsy. Sleep Med. 43, 14–18 (2018).
  Article PubMed Google Scholar
• Fortuyn, H. A., Mulders, P. C., Renier, Buitelaar, W. O., J. K. & Overeem, S. Narcolepsy and psychiatry: an evolving association of increasing interest. Sleep Med. 12, 714–719 (2011).
  Article PubMed Google Scholar
• Rosenthal, C. Über das Auftreten von halluzinatorisch-kataplektischen Angstsyndrom, Wachanfällen und ähnlichen Störungen bei Schizophrenen [German]. Monatschr. Psychiatr. Neurol. 102, 11–38 (1939).
  Article Google Scholar
• Nissen, C. et al. Transient narcolepsy-cataplexy syndrome after discontinuation of the antidepressant venlafaxine. J. Sleep Res. 14, 207–208 (2005).
  Article PubMed Google Scholar
• Plazzi, G., Khatami, R., Serra, Pizza, L., F. & Bassetti, C. L. Pseudocataplexy in narcolepsy-cataplexy. Sleep Med. 11, 591–594 (2010).
  Article PubMed Google Scholar
• Krahn, L. E., Hansen, M. R. & Shepard, J. W. Pseudocataplexy. Psychosomatics 42, 356–358 (2001).
  Article CAS PubMed Google Scholar
• Ponz, A. et al. Abnormal activitiy in reward brain circuits in human narcolepsy with cataplexy. Ann. Neurol. 67, 190–200 (2010).
  Article PubMed Google Scholar
• Ponz, A. et al. Reduced amygdala activity during aversive conditioning in human narcolepsy. Ann. Neurol. 67, 394–398 (2010).
  Article PubMed Google Scholar
• Georgescu, D. et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J. Neurosci. 23, 3106–3111 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Broughton, R. J., Guberman, A. & Roberts, J. Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study. Epilepsia 25, 423–433 (1984).
  Article CAS PubMed Google Scholar
• Ohayon, M. M. et al. Increased mortality in narcolepsy. Sleep 37, 439–444 (2014).
  Article PubMed PubMed Central Google Scholar
• Pizza, F. et al. Car crashes and central disorders of hypersomnolence: a French study. PLOS ONE 10, e0129386 (2015).
  Article PubMed PubMed Central CAS Google Scholar
• Blackwell, J. E., Alammar, H. A., Weighall, A. R., Kellar, I. & Nash, H. M. A systematic review of cognitive function and psychosocial well-being in school-age children with narcolepsy. Sleep Med. Rev. 34, 82–93 (2017).
  Article PubMed Google Scholar
• Szakacs, Z., Hallbook, T., Tideman, P., Darin, N. & Wentz, E. Psychiatric comorbidity and cognitive profile in children with narcolepsy with or without association to the H1N1 influenza vaccnination. Sleep 38, 615–621 (2015).
  Article PubMed PubMed Central Google Scholar
• Douglas, N. J. The psychosocial aspects of narcolepsy. Neurology 50, S27–S30 (1998).
  Article CAS PubMed Google Scholar
• Goswami, M. The influence of clinical symptoms on quality of life in patients with narcolepsy. Neurology 50, S31–S36 (1998).
  Article CAS PubMed Google Scholar
• Oosterloo, M., Lammers, G. J., Overeem, S., de Noord, I. & Kooij, J. J. Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder. Psychiatry Res. 143, 293–297 (2006).
  Article PubMed Google Scholar
• Filardi, M. et al. Attention impairments and ADHD symptoms in adult narcoleptic patients with and without hypocretin deficiency. PLOS ONE 12, e0182085 (2017).
  Article PubMed PubMed Central CAS Google Scholar
• Naumann, A., Bellebaum, C. & Daum, I. Cognitive deficits in narcolepsy. J. Sleep Res. 15, 329–338 (2006).
  Article CAS PubMed Google Scholar
• Zamarian, L. et al. Subjective deficits of attention, cognition and depression in patients with narcolepsy. Sleep Med. 16, 45–51 (2015).
  Article PubMed Google Scholar
• Bayard, S. et al. Executive control of attention in narcolepsy. PLOS ONE 7, e33525 (2012).
  Article CAS PubMed PubMed Central Google Scholar
• Jennum, J. et al. Cerebrospinal fluid biomarkers of neurodegeneration are decreased or normal in narcolepsy. Sleep 40, zsw006 (2017).
  Google Scholar
• Economou, N. T., Manconi, M., Ghika, J., Raimondi, M. & Bassetti, C. L. Development of Parkinson and Alzheimer diseases in two cases of narcolepsy-cataplexy. Eur. Neurol. 67, 48–50 (2012).
  Article PubMed Google Scholar
• Roberts, H. J. Obesity due to the syndrome of narcolepsy and diabetogenic hyperinsulinism: clinical and therapeutic observations on 252 patients. J. Am. Geriatr. Soc. 15, 721–743 (1967).
  Article CAS Google Scholar
• Schuld, A., Hebebrand, J., Geller, F. & Pöllmächer, T. Increased body mass index in patients with narcolepsy. Lancet 355, 1274–1275 (2000).
  Article CAS PubMed Google Scholar
• Kok, S. W. et al. Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans. J. Clin. Endocrinol. Metab. 87, 805–809 (2002).
  Article CAS PubMed Google Scholar
• Donjacour, C. E. et al. Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study. Sleep 37, 795–801 (2014).
  Article PubMed PubMed Central Google Scholar
• Poli, F. et al. High prevalence of precocious puberty and obesity in childhood narcolepsy with cataplexy. Sleep 36, 175–181 (2013).
  Article PubMed PubMed Central Google Scholar
• van Holst, R. J. et al. Aberrant food choices after satiation in human orexin-deficient narcolepsy type 1. Sleep 39, 1951–1959 (2016).
  Article PubMed PubMed Central Google Scholar
• Nishino, S. et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann. Neurol. 50, 381–388 (2001).
  Article CAS PubMed Google Scholar
• Kok, S. W. et al. Altered setting of the pituitary-thyroid ensemble in hypocretin-deficient narcoleptic men. Am. J. Physiol. Endocrinol. Metab. 288, E892–E899 (2005).
  Article CAS PubMed Google Scholar
• Plazzi, G. et al. Autonomic disturbances in narcolepsy. Sleep Med. Rev. 15, 187–196 (2011).
  Article PubMed Google Scholar
• Stiasny-Kolster, K. et al. Combination of ‘idiopathic’ REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128, 126–137 (2005).
  Article CAS PubMed Google Scholar
• Bayard, S. et al. Olfactory dysfunction in narcolepsy with cataplexy. Sleep Med. 11, 876–881 (2010).
  Article PubMed Google Scholar
• Black, J. et al. Medical comorbidity in narcolepsy: findings from the Burden of Narcolepsy Disease (BOND) study. Sleep Med. 33, 13–18 (2017).
  Article CAS PubMed Google Scholar
• Lecendreux, M. Pediatric narcolepsy: clinical and therapeutical approach. Handb. Clin. Neurol. 112, 839–845 (2013).
  Article Google Scholar
• Vandi, S. et al. A standardized test to document cataplexy. Sleep Med. 53, 197–204 (2017).
  Article PubMed Google Scholar
• Baumann, C. R., Khatami, R., Werth, E. & Bassetti, C. L. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy. J. Neurol. Neurosurg. Psychiatry 77, 402–404 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Gerashchenko, D. et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J. Neurosci. 21, 7273–7283 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Baumann, C. R. & Bassetti, C. L. Hypocretins (orexins) and sleep-wake disorders. Lancet Neurol. 10, 673–682 (2005).
  Article Google Scholar
• Baumann, C. R., Dauvilliers, Y., Mignot, E. & Bassetti, C. L. Normal CSF hypocretin-1 (orexin-A) levels in dementia with Lewy bodies. Eur. Neurol. 52, 73–76 (2004).
  Article CAS PubMed Google Scholar
• Mayer, G. & Lammers, G. J. The MSLT: more objections than benefits as a diagnostic gold standard? Sleep 37, 1027–1028 (2014).
  Article PubMed PubMed Central Google Scholar
• Sakai, N., Matsumura, M., Lin, L., Mignot, E. & Nishino, S. HLPC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci. Rep. 9, 477 (2019).
  Article PubMed PubMed Central CAS Google Scholar
• Mignot, E. et al. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults. Brain 129, 1609–1623 (2006).
  Article PubMed Google Scholar
• Goldbart, A. et al. Narcolepsy and predictors of positive MSLTs in the Wisconsin sleep cohort. Sleep 37, 1043–1051 (2014).
  Article PubMed PubMed Central Google Scholar
• Zhang, Z. et al. Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning. Sci. Rep. 8, 10628 (2018).
  Article PubMed PubMed Central CAS Google Scholar
• Bassetti, C. & Aldrich, M. S. Idiopathic hypersomnia. A series of 42 patients. Brain 120, 1423–1435 (1997).
  Article PubMed Google Scholar
• Berti Ceroni, G., Coccagna, G., Gambi, D. & Lugaresi, E. Considerazioni clinico-poligrafiche sulla narcolessia essenziale “a sonno lento” [Italian]. Sist. Nerv. 2, 81–89 (1967).
  Google Scholar
• Hishikawa, Y. et al. The nature of sleep attack and other symptoms of narcolepsy. Electroencephalogr. Clin. Neurophysiol. 24, 1–10 (1968).
  Article CAS PubMed Google Scholar
• Melberg, A. et al. Autosomal dominant cerebellar ataxia deafness and narcolepsy. J. Neurol. Sci. 134, 119–129 (1995).
  Article CAS PubMed Google Scholar
• Moghadam, K. K. et al. Narcolepsy is a common phenotype in HSAN IE and ADCA-DN. Brain 137, 1643–1655 (2014).
  Article PubMed Google Scholar
• D’Cruz, O. F., Vaughn, B. V., Gold, S. H. & Greenwood, R. S. Symptomatic cataplexy in pontomedullary lesions. Neurology 44, 2189–2191 (1994).
  Article PubMed Google Scholar
• Kanbayashi, T. Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications. Arch. Neurol. 66, 1563–1566 (2009).
  Article PubMed Google Scholar
• Mathis, J., Hess, C. W. & Bassetti, C. Isolated mediotegmental lesion causing narcolepsy and rapid eye movement sleep behaviour disorder: a case evidencing a common pathway in narcolepsy and rapid eye movement sleep behaviour disorder. J. Neurol. Neurosurg. Psychiatry 78, 427–429 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartz, W. J., Stakes, J. W. & Hobson, J. A. Transient cataplexy after removal of a craniopharyngioma. Neurology 34, 1372–1375 (1984).
  Article CAS PubMed Google Scholar
• Bonduelle, M. & Degos, C. in Narcolepsy: Proceedings of the First International Symposium on Narcolepsy (eds Guilleminault, C. et al.) 313–332 (Spectrum, 1976).
• Stahl, S. M., Layzer, R. B., Aminoff, M. J., Townsend, J. J. & Feldon, S. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 30, 1115–1118 (1980).
  Article CAS PubMed Google Scholar
• Fernandez, J. M., Sadaba, F., Villaverde, F. J., Alvaro, L. C. & Cortina, C. Cataplexy associated with midbrain lesion. Neurology 45, 393–394 (1995).
  Article CAS PubMed Google Scholar
• Roehrs, T., Zorick, F., Sicklesteel, J., Wittig, R. & Roth, T. Excessive daytime sleepiness associated with insufficient sleep. Sleep 6, 319–325 (1983).
  Article CAS PubMed Google Scholar
• Baumann, C., Ferini-Strambi, L., Waldvogel, D., Werth, E. & Bassetti, C. L. Parkinsonism with excessive daytime sleepiness — a narcolepsy-like disorder? J. Neurol. 252, 139–145 (2005).
  Article PubMed Google Scholar
• Kaplan, K. A. & Harvey, A. G. Hypersomnia across mood disorders: a review and synthesis. Sleep Med. Rev. 13, 275–285 (2009).
  Article PubMed Google Scholar
• McLeod, S., Ferrie, C. & Zuberi, S. M. Symptoms of narcolepsy in children misinterpreted as epilepsy. Epileptic Disord. 7, 13–17 (2005).
  Google Scholar
• Paskind, H. A. Effect of laughter on muscle tone. Arch. Neurol. Psychiatry 28, 623–628 (1932).
  Article Google Scholar
• Partinen, M. Sleeping habits and sleep disorders of Finnish men before, during and after military service. Ann. Med. Milit. Fenn. 57 (Suppl. 1), 1–96 (1982).
  Google Scholar
• Overeem, S., Lammers, G. J. & van Dijk, J. G. Weak with laughter. Lancet 354, 838 (1999).
  Article CAS PubMed Google Scholar
• Kim, L. J. et al. Frequencies and associations of narcolepsy-related symptoms: a cross-sectional study. J. Clin. Sleep Med. 11, 1377–1384 (2015).
  Article PubMed PubMed Central Google Scholar
• Parkes, J. D. Genetic factors in human sleep disorders with special reference to Norrie disease, Prader–Willi syndrome and Moebius syndrome. J. Sleep Res. 8 (Suppl. 1), 14–22 (1999).
  Article PubMed Google Scholar
• Iranzo, A. & Santamaria, J. Hyperkalemic periodic paralysis associated with multiple sleep onset REM periods. Sleep 22, 1123–1124 (1999).
  Article CAS PubMed Google Scholar
• Hartse, K. M., Zorick, F., Sicklesteel, J. & Roth, T. Isolated cataplexy: a familial study. Henry Ford Hosp. Med. J. 36, 24–27 (1988).
  CAS PubMed Google Scholar
• Kishi, Y. et al. Schizophrenia and narcolepsy: a review with a case report. Psychiatry Clin. Neurosci. 58, 117–124 (2004).
  Article PubMed Google Scholar
• Bassetti, C. L. in Handbook of Clinical Neurology 169–190 (Elsevier, 2014).
• Antelmi, E., Pizza, F., Vandi, S. & Plazzi, G. Stereotyped episodes of aphasia and immobility: how cataplexy mimics stroke in an elderly patient. Sleep Med. 36, 122–124 (2017).
  Article CAS PubMed Google Scholar
• Leu-Semenscu, S. et al. Hallucinations in narcolepsy with and without cataplexy: contrasts with Parkinson’s disease. Sleep Med. 12, 497–504 (2011).
  Article Google Scholar
• Cheyne, J. A., Newby-Clark, I. R. & Rueffer, S. D. Relations among hypnagogic and hypnopompic experiences associated with sleep paralysis. J. Sleep Res. 8, 313–318 (1999).
  Article CAS PubMed Google Scholar
• Dahmen, N., Kasten, M., Müller, M. J. & Mittag, K. Frequency and dependence on body posture of hallucinations and sleep paralysis in a community sample. J. Sleep Res. 11, 179–180 (2002).
  Article PubMed Google Scholar
• Ohayon, M. M. & Smirne, S. Prevalence and consequences of insomnia disorders in the general population of Italy. Sleep Med. 3, 115–120 (2002).
  Article PubMed Google Scholar
• Kallweit, U., Schmidt, M. & Bassetti, C. L. Patient-reported measures of narcolepsy: the need for better assessment. J. Clin. Sleep Med. 13, 737–744 (2017).
  Article PubMed PubMed Central Google Scholar
• Sturzenegger, C. et al. Swiss Narcolepsy Scale: a simple screening tool for hypocretin-deficient narcolepsy with cataplexy. Clin. Transl Neurosci. 2, 1–5 (2018).
  Article Google Scholar
• Aldrich, M. S., Chervin, R. D. & Malow, B. A. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 20, 620–629 (1997).
  CAS PubMed Google Scholar
• Dauvilliers, Y. et al. Effect of age on MSLT results in patients with narcolepsy-cataplexy. Neurology 62, 46–50 (2004).
  Article CAS PubMed Google Scholar
• Singh, M., Drake, C. L. & Roth, T. The prevalence of multiple sleep-onset REM periods in a population-based sample. Sleep 29, 890–895 (2016).
  Article Google Scholar
• Huang, Y. S. et al. Multiple sleep latency test in narcolepsy type 1 and narcolepsy type 2: a 5-year follow-up study. J. Sleep Res. 27, e12700 (2018).
  Article PubMed Google Scholar
• Marti, I., Valko, P. O., Khatami, R., Bassetti, C. L. & Baumann, C. R. Multiple sleep latency measures in narcolepsy and behaviourally insufficient sleep syndrome. Sleep Med. 10, 1146–1150 (2009).
  Article PubMed Google Scholar
• Drakatos, P. et al. First rapid eye movement sleep periods and sleep-onset rapid eye movement periods in sleep-stage sequencing of hypersomnias. Sleep Med. 14, 897–901 (2013).
  Article PubMed Google Scholar
• Cairns, A. & Bogan, R. Prevalence and clinical correlates of a short onset REM period (SOREMP) during routine PSG. Sleep 38, 1575–1581 (2015).
  Article PubMed PubMed Central Google Scholar
• Pizza, F. et al. Spectral electroencephalography profile of rapid eye movement sleep at sleep onset in narcolepsy type 1. Eur. J. Neurol. 24, 334–340 (2017).
  Article CAS PubMed Google Scholar
• Pizza, F. et al. Nocturnal sleep dynamics identify narcolepsy type 1. Sleep 38, 1277–1284 (2015).
  Article PubMed PubMed Central Google Scholar
• Sakai, N., Mastsumura, M., Lin, L., Mignot, E. & Nishino, S. HPLC analysis of CSF hypocretin-1 in type 1 and 2 narcolepsy. Sci. Rep. 9, 477 (2019).
  Article PubMed PubMed Central CAS Google Scholar
• Bassetti, C., Aldrich, M. S. & Quint, D. J. MRI findings in narcolepsy. Sleep 20, 630–631 (1997).
  Article CAS PubMed Google Scholar
• Plazzi, G. et al. Pontine lesions in idiopathic narcolepsy. Neurology 46, 1250–1254 (1996).
  Article CAS PubMed Google Scholar
• Kaufmann, C., Schuld, A., Pöllmächer, T. & Auer, D. P. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology 58, 1852–1855 (2002).
  Article PubMed Google Scholar
• Overeem, S. et al. Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep 26, 44–46 (2003).
  PubMed Google Scholar
• Poryazova, R. et al. Magnetic resonance spectroscopy in narcolepsy [abstract]. Sleep 29, A222 (2006).
  Google Scholar
• Schaer, M., Poryazova, R., Schwartz, S., Bassetti, C. L. & Baumann, C. R. Cortical morphometry in narcolepsy with cataplexy. J. Sleep Res. 21, 487–494 (2012).
  Article PubMed Google Scholar
• Wada, M. et al. Neuroimaging correlates of narcolepsy with cataplexy: a systematic review. Neurosci. Res. https://doi.org/10.1016/j.neures.2018.03.005 (2018).
  Article PubMed Google Scholar
• Meletti, S. et al. The brain correlates of laugh and cataplexy in childhood narcolepsy. J. Neurosci. 35, 11583–11594 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Schwartz, S. et al. Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy. Brain 131, 514–522 (2008).
  Article PubMed Google Scholar
• Reiss, A. L. et al. Anomalous hypothalamic response to humor in cataplexy. PLOS ONE 3, e2225 (2008).
  Article PubMed PubMed Central CAS Google Scholar
• Siegel, J. M. et al. Neuronal-activity in narcolepsy: Identification of cataplexy-related cells in the medial medulla. Science 252, 1315–1318 (1991).
  Article CAS PubMed PubMed Central Google Scholar
• Aldrich, M. Narcolepsy. N. Engl. J. Med. 323, 389–394 (1990).
  Article CAS PubMed Google Scholar
• Apergis-Schoute, J. et al. Optogenetic evidence for inhibitory signaling from orexin to MCH neurons via local microcircuits. J. Neurosci. 35, 5435–5441 (2015).
  Article CAS PubMed PubMed Central Google Scholar
• Schöne, C., Apergis-Schoute, J., Sakurai, T., Adamantidis, A. & Burdakov, D. Coreleased orexin and glutamate evoke nonredundant spike outputs and computations in histamine neurons. Cell Rep. 7, 697–704 (2014).
  Article PubMed PubMed Central CAS Google Scholar
• van den Top, M., Lee, K., Whyment, A. D., Blanks, A. M. & Spanswick, D. Orexigen-sensitive NPY/AgRP pacemaker neurons in the hypothalamic arcuate nucleus. Nat. Neurosci. 7, 493–494 (2004).
  Article PubMed CAS Google Scholar
• Belle, M. D. et al. Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock. J. Neurosci. 34, 3607–3621 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Lee, M. G., Hassani, O. K. & Jones, B. E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 25, 6716–6720 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437–451 (1999).
  Article CAS PubMed Google Scholar
• Lin, L. et al. The sleep disorder of canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365–376 (1999).
  Article CAS PubMed Google Scholar
• Hasegawa, E., Yanagisawa, M., Sakurai, T. & Mieda, M. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. J. Clin. Invest. 124, 604–616 (2014).
  Article CAS PubMed PubMed Central Google Scholar
• Irukayama-Tomobe, Y. et al. Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models. Proc. Natl Acad. Sci. USA 114, 5731–5736 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Kaushik, M. K. et al. Continuous intrathecal orexin delivery inhibits cataplexy in a murine model of narcolepsy. Proc. Natl Acad. Sci. USA 115, 6046–6051 (2018).
  Article CAS PubMed PubMed Central Google Scholar
• Black, S. W. et al. Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration. Sleep 41, zsy116 (2018).
  Article Google Scholar
• Lin, J. S. Brain structures and mechanisms involved in the control of cortical activation and wakefulness, with emphasis on posterior hypothalamus and histaminergic neurons. Sleep Med. Rev. 4, 471–503 (2000).
  Article CAS PubMed Google Scholar
• Kanbayashi, T. et al. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome. Sleep 32, 181–187 (2009).
  Article PubMed PubMed Central Google Scholar
• Nishino, S. et al. Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls. Sleep 32, 175–180 (2009).
  Article PubMed PubMed Central Google Scholar
• Bassetti, C. L. et al. Cerebrospinal fluid histamine levels are decreased in patients with narcolepsy and excessive daytime sleepiness of other origin. J. Sleep Res. 19, 620–623 (2010).
  Article PubMed Google Scholar
• Dauvilliers, Y. et al. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Sleep 35, 1359–1366 (2012).
  Article PubMed PubMed Central Google Scholar
• Lin, J. S. et al. An inverse agonist of the histamine H3 receptor improves wakefulnesss in narcolepsy: studies in orexin−/− mice and patients. Neurobiol. Dis. 30, 74–83 (2008).
  Article PubMed CAS Google Scholar
• Jordan, W. et al. Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep 27, 867–874 (2004).
  Article PubMed Google Scholar
• Jordan, W. et al. Narcolepsy increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J. Neurol. 252, 1372–1378 (2005).
  Article CAS PubMed Google Scholar
• Bassetti, C. L., Hersberger, M. & Baumann, C. R. CSF prostaglandin D synthase is reduced in excessive daytime sleepiness. J. Neurol. 253, 1030–1033 (2006).
  Article CAS PubMed Google Scholar
• Peyron, C. et al. Neurons containing hypocretin (orexin) project to multiple neuronal system. J. Neurosci. 18, 9996–10015 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Boissard, R. et al. The rat ponto-medullary network responsible for paradoxical sleep onset and maintenance: a combined microinjection and functional neuroanatomical study. Eur. J. Neurosci. 16, 1959–1973 (2002).
  Article PubMed Google Scholar
• Lu, J., Sherman, D., Devor, M. & Saper, C. B. A putative flip-flop switch for control of REM sleep. Nature 441, 589–594 (2006).
  Article CAS PubMed Google Scholar
• Okura, M., Riehl, J., Mignot, E. & Nishino, S. Sulpiride, a D2/D3 blocker reduces cataplexy but not REM sleep in canine narcolepsy. Neuropsychopharmacology 23, 528–538 (2000).
  Article CAS PubMed Google Scholar
• Vu, M. H., Hurni, C., Mathis, J., Roth, C. & Bassetti, C. L. Selective REM sleep deprivation in narcolepsy. J. Sleep Res. 20, 50–56 (2011).
  Article PubMed Google Scholar
• Overeem, S., Lammers, G. J. & van Dijk, J. G. Cataplexy: ‘tonic immobility’ rather than ‘REM-sleep atonia’? Sleep Med. 3, 471–477 (2002).
  Article PubMed Google Scholar
• Hishikawa, Y. et al. Characteristics of REM sleep accompanied by sleep paralysis and hypnagogic hallucinations in narcoleptic patients. Waking Sleeping 2, 113–123 (1978).
  Google Scholar
• Terzaghi, M., Ratti, P. L., Manni, F. & Manni, R. Sleep paralysis in narcolepsy: more than just a motor dissociative phenomenon? Neurol. Sci. 33, 169–172 (2012).
  Article PubMed Google Scholar
• Snow, M. B. et al. GABA cells in the central nucleus of the amygdala promote cataplexy. J. Neurosci. 37, 4007–4022 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Mahoney, C. E., Agostinelli, L. J., Brooks, J. N., Lowell, B. B. & Scammell, T. E. GABAergic neurons of the central amygdala promote cataplexy. J. Neurosci. 37, 3995–4006 (2017).
  Article CAS PubMed PubMed Central Google Scholar
• Gulyani, S., Wu, M. F., Nienhuis, R., John, J. & Siegel, J. M. Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience 112, 355–365 (2002).
  Article CAS PubMed Google Scholar
• Burgess, C. R., Oishi, Y., Mochizuki, T., Peever, J. H. & Scammell, T. E. Amygdala lesions reduce cataplexy in orexin knock-out mice. J. Neurosci. 33, 9734–9742 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Hong, S. B., Tae, W. S. & Joo, E. Y. Cerebral perfusion changes during cataplexy in narcolepsy patients. Neurology 66, 1747–1749 (2006).
  Article PubMed Google Scholar
• Tucci, V. et al. Emotional information processing in patients with narcolepsy: a psychophysiologic investigation. Sleep 26, 558–564 (2003).
  Article PubMed Google Scholar
• Khatami, R., Birkmann, S. & Bassetti, C. L. Amygdala dysfunction in narcolepsy-cataplexy. J. Sleep Res. 16, 226–229 (2007).
  Article PubMed Google Scholar
• Oishi, Y. et al. Role of the medial prefrontal cortex in cataplexy. J. Neurosci. 33, 9743–9751 (2013).
  Article CAS PubMed PubMed Central Google Scholar
• Vassalli, A. et al. Electroencephalogram paroxysmal θ characterizes cataplexy in mice and children. Brain 136, 1592–1608 (2013).
  Article PubMed Google Scholar
• van der Heide, A. et al. Comparing treatment effect measurements in narcolepsy: the sustained attention to response task, Epworth sleepiness scale and maintenance of wakefulness test. Sleep 38, 1051–1058 (2015).
  Article PubMed PubMed Central Google Scholar
• Bogan, R. et al. Evaluation of quality of life in patients with narcolepsy treated with sodium oxybate: use of the 36-item short-form health survey in a clinical trial. Neurol. Ther. 5, 203–213 (2016).
  Article PubMed PubMed Central Google Scholar
• Filardi, M. et al. Physical activity and sleep/wake behavior, anthropometric, and metabolic profile in pediatric narcolepsy type 1. Front. Neurol. 9, 707 (2018).
  Article PubMed PubMed Central Google Scholar
• Yoss, R. E. & Daly, D. Treatment of narcolepsy with ritalin. Neurology 9, 171–173 (1959).
  Article CAS PubMed Google Scholar
• Hishikawa, Y., Ida, H., Nakai, K. & Kaneko, Z. Treatment of narcolepsy with imipramine (tofranil) and desmethylimipramine (pertofran). J. Neurol. Sci. 3, 453–461 (1966).
  Article CAS PubMed Google Scholar
• Frey, J. & Darbonne, C. Fluoxetine suppresses human cataplexy: a pilot study. Neurology 44, 707–709 (1994).
  Article CAS PubMed Google Scholar
• Kallweit, U. & Bassetti, C. L. Pharmacological management of narcolepsy with and without cataplexy. Expert Opin. Pharmacother. 18, 809–817 (2017).
  Article CAS PubMed Google Scholar
• Broughton, R. et al. Randomized, double blind, placebo-controlled cross-over trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy. Neurology 49, 444–451 (1997).
  Article CAS PubMed Google Scholar
• US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann. Neurol. 43, 88–97 (1998).
  Article Google Scholar
• US Xyrem Multicenter Study Group. Sodium oxybate demonstrates long-term efficacy for the treatment of cataplexy in patients with narcolepsy. Sleep Med. 5, 119–123 (2004).
  Article Google Scholar
• US Xyrem Multicenter Study Group. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 26, 31–35 (2003).
  Google Scholar
• Dauvilliers, Y. et al. Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial. Lancet Neurol. 12, 1068–1075 (2013).
  Article CAS PubMed Google Scholar
• Szakacs, Z. et al. Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 16, 200–207 (2017).
  Article CAS PubMed Google Scholar
• Thannickal, T. C. et al. Opiates increase the number of hypocretin-producing cells in human and mouse brain and reverse cataplexy in a mouse model of narcolepsy. Sci. Transl Med. 10, eaao4953 (2018).
  Article PubMed CAS PubMed Central Google Scholar
• Harper, J. M. Gelineau’s narcolepsy relieved by opiates. Lancet 10, 92 (1981).
  Article Google Scholar
• Fry, J. M., Pressman, M. R., DiPhilippo, M. A. & Forst-Paulus, M. Treatment of narcolepsy with codeine. Sleep 9, 269–274 (1986).
  Article CAS PubMed Google Scholar
• Billiard, M. et al. EFNS guidelines on management of narcolepsy. Eur. J. Neurol. 13, 1035–1048 (2006).
  Article CAS PubMed Google Scholar
• Mignot, E. J. A practical guide to the therapy of narcolepsy and hypersomnia syndromes. Neurotherapeutics 9, 739–752 (2012).
  Article PubMed PubMed Central Google Scholar
• Bogan, R. K., Roth, T., Schwartz, J. & Miloslavsky, M. Time to response with sodium oxybate for the treatment if excessive daytime sleepiness and cataplexy in patients with narcolepsy. J. Clin. Sleep Med. 11, 427–432 (2015).
  PubMed PubMed Central Google Scholar
• Thorpy, M. J. et al. A randomized study of solriamfetol for excessive sleepiness in narcolepsy. Ann. Neurol. 85, 359–370 (2019).
  Article CAS PubMed PubMed Central Google Scholar
• Ruoff, C. et al. Effect of oral JZP-110 (ADX-N05) on wakefulness and sleepiness in adults with narcolepsy: a phase 2b study. Sleep 39, 1379–1387 (2016).
  Article PubMed PubMed Central Google Scholar
• Mitler, M. M., Hajdukovic, R. & Erman, M. K. Treatment of narcolepsy with methamphetamine. Sleep 16, 306–317 (1993).
  Article CAS PubMed Google Scholar
• Jin, L. et al. Antidepressants for the treatment of narcolepsy: a prospective study of 148 patients in northern China. J. Clin. Neurosci. https://doi.org/10.1016/j.jocn.2019.02.014 (2019).
  Article PubMed Google Scholar
• Lehert, P. & Falissard, B. Multiple treatment comparison in narcolepsy: a network meta-analysis. Sleep 41, zsy185 (2018).
  Article PubMed Central Google Scholar
• Roth, T. et al. Effect of sodium oxybate on disrupted nighttime sleep in patients with narcolepsy. J. Sleep Res. 26, 407–414 (2016).
  Article PubMed Google Scholar
• Plazzi, G. et al. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation. Lancet Child Adolesc. Health 2, 483–494 (2018).
  Article PubMed Google Scholar
• Calvo-Ferrandiz, E. & Peraita-Adrados, R. Narcolepsy with cataplexy and pregnancy: a case–control study. J. Sleep Res. 27, 268–272 (2017).
  PubMed Google Scholar
• Maurovich-Horvat, E. et al. Narcolepsy and pregnancy: a retrospective European evaluation of 249 pregnancies. J. Sleep Res. 22, 496–512 (2013).
  Article PubMed Google Scholar
• Dauvilliers, Y., Carlander, B., Rivier, F., Touchon, J. & Tafti, M. Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann. Neurol. 56, 905–908 (2004).
  Article CAS PubMed Google Scholar
• Miyata, R., Hayashi, M., Kohyama, J. & Honda, M. Steroid therapy ameliorated cataplexy in three children with recent-onset of narcolepsy. Sleep Med. 29, 86–87 (2017).
  Article PubMed Google Scholar
• Donjacur, C. E. & Lammers, G. J. A remarkable effect of alemtuzumab in a patient suffering from narcolepsy with cataplexy. J. Sleep Res. 21, 479–480 (2012).
  Article Google Scholar
• Liblau, R. S., Vassalli, A., Seifinejad, A. & Tafti, M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol. 14, 318–328 (2015).
  Article CAS PubMed Google Scholar
• Bernard-Valnet, R. et al. CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice. Proc. Natl Acad. Sci. USA 113, 10956–10961 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Krahn, L. E., Boeve, B. F., Olson, E. J., Herold, D. L. & Silber, M. H. A standardized test for cataplexy. Sleep Med. 1, 125–130 (2000).
  Article CAS PubMed Google Scholar
• Olsen, A. V. et al. Diagnostic value of sleep stage dissociation as visualized on a 2-dimensional sleep state space in human narcolepsy. J. Neurosci. Methods 282, 9–19 (2017).
  Article PubMed Google Scholar
• Hirtz, C. et al. From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid. Sci. Rep. 6, 25162 (2016).
  Article CAS PubMed PubMed Central Google Scholar
• Stephansen, J. B. et al. Neural network analysis of sleep stages enables efficient diagnosis of narcolepsy. Nat. Commun. 9, 5229 (2018).
  Article PubMed PubMed Central CAS Google Scholar
• Rosenberg, R. & Kim, A. Y. The AWAKEN survey: knowledge of narcolepsy among physicians and the general population. Postgrad. Med. 126, 78–86 (2014).
  Article PubMed Google Scholar
• Maski, K. et al. Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy. J. Clin. Sleep Med. 13, 419–425 (2017).
  Article PubMed PubMed Central Google Scholar
• Chaplin, J. E., Szakács, A. & Hallböök, Darin, T. N. The development of a health-related quality-of-life instrument for young people with narcolepsy: NARQoL-21. Health Qual. Life Outcomes 15, 135 (2017).
  Article PubMed PubMed Central Google Scholar
• Dauvilliers, Y. et al. Measurement of narcolepsy symptoms: the Narcolepsy Severity Scale. Neurology 88, 1358–1365 (2017).
  Article PubMed Google Scholar